The Limitations and Promise of Immunotherapy With Chimeric Antigen-Modified T Cells
- PMID: 27744646
The Limitations and Promise of Immunotherapy With Chimeric Antigen-Modified T Cells
Comment on
-
The Promise of Chimeric Antigen Receptor T-Cell Therapy.Oncology (Williston Park). 2016 Oct 15;30(10):880-8, 890. Oncology (Williston Park). 2016. PMID: 27744645 Review.